Helping skin cells differentiate could be key to treating common skin cancer

Helping skin cells differentiate could be key to treating common skin cancer
Brian C. Capell, M.D., Ph.D. Credit: Penn Medicine

The outer layer of the skin completely replaces itself every two to four weeks, but when this process is blocked, cancer can grow. A new study from researchers in the Perelman School of Medicine at the University of Pennsylvania has now identified a key regulator of that block known as LSD1, as well as a way to genetically influence the skin to grow in a way that prevents this block from happening. This is the first study to show that LSD1—a regulator involved in telling parent cells what type of specific cells their lineage should become as they reproduce—plays a role in the growth of non-melanoma skin cancers, and that blocking LSD1 could be an effective, targeted treatment method for those cancers, which are the most common in the world. The journal Cell Reports published the findings today.

Cutaneous squamous cell carcinoma (cSCC) is a caused by the abnormal growth of skin . Together with a similar type of cancer known as (BCC), they outnumber all other human cancers combined. While many patients can have these cancers removed, others are not candidates for surgery and need alternative treatment options, which can include chemotherapy. Previous research has shown that these types of cancers thrive when skin cells, which are constantly renewing, don't differentiate themselves as they reproduce.

"Our study shows that targeting LSD1 can force the skin cells down a differentiation path, which could open the door to new topical therapies that can ultimately turn tumor cells into healthier, more normal cells," said the study's senior author Brian C. Capell, MD, Ph.D., an assistant professor of Dermatology and a member of Penn's Epigenetics Institute and Abramson Cancer Center. The co-lead authors on the study are Shaun Egolf, a , and Yann Aubert, Ph.D., a postdoctoral fellow, both in Capell's lab.

LSD1 is typically elevated in many types of , and there are several inhibitors that attempt to target it. But until now, no one has shown its role in repressing the genes the skin needs for healthy turnover. That knowledge could open the door to a new treatment method that blocks LSD1 with a skin cream or other topical therapy.

"By knocking out LSD1, we can essentially turn the switch back on that would tell the to differentiate in a healthy way," Capell said.

Researchers say work is already underway to prove the concept can work, which would pave the way for human clinical trials.


Explore further

Highly mutated protein in skin cancer plays central role in skin cell renewal

Journal information: Cell Reports

Citation: Helping skin cells differentiate could be key to treating common skin cancer (2019, August 20) retrieved 15 September 2019 from https://medicalxpress.com/news/2019-08-skin-cells-differentiate-key-common.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
74 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more